Decoy Therapeutics【DCOY】銘柄情報

Decoy Therapeutics Inc (DCOY) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

5.90

( 5.55% )

買値

5.70

売値

6.00

出来高

7,620

5.50 日の範囲 6.00

0.5348 52 週間の範囲 9.57

時価総額

3.139M

前日終値

5.59

始値

5.59

時刻

5.9489

最終取引時間

06:20:24

財務取引量

US$ 44,251

VWAP

5.8072

平均取引量 (3 か月)

US$ 23,062

発行済株式数

531,968

配当利回り

PER

-0.1

1 株当たり利益 (EPS)

-57.12

歳入

純利益

-13.03M

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to de... Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

decoytx.com

本社

Houston, United States

設立

Decoy Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker DCOY. The last closing price for Decoy Therapeutics was US$5.59. Over the last year, Decoy Therapeutics shares have traded in a share price range of US$ 0.5348 to US$ 9.57.

Decoy Therapeutics currently has 531,968 shares in issue. The market capitalisation of Decoy Therapeutics is US$3.14 million. Decoy Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2.05	-25.786163522	7.95	7.95	5.06	19531	6.17524801	CS
4	1.21	25.7995735608	4.69	9.57	4.3201	17724	6.91363977	CS
12	-2.05	-25.786163522	7.95	9.57	4.3201	19968	6.29911293	CS
26	5.1389	675.19379845	0.7611	9.57	0.5348	1181320	1.27073466	CS
52	5.1389	675.19379845	0.7611	9.57	0.5348	1181320	1.27073466	CS
156	5.1389	675.19379845	0.7611	9.57	0.5348	1181320	1.27073466	CS
260	5.1389	675.19379845	0.7611	9.57	0.5348	1181320	1.27073466	CS